A Prospective Registry Study on Biological Disease Profile, Intervention Type and Clinical Outcome in Adolescent and Adult Patients With Soft-tissue and Bone Sarcoma

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

SarcBOP - An interdisciplinary and translational registry SarcBOP aims to establish a database that integrates every aspect possibly relevant to sarcoma treatment and research. SarcBOP thus will not be limited to specific questions or patient groups, but instead will build a comprehensive database including clinical, pathologic, and radiologic information, multi-layered molecular data, and patient-reported outcomes, combined with a dedicated biobank for tissue samples and liquid biopsies. As the study integrates seamlessly with the clinical activities of the Heidelberg Sarcoma Center, the Molecular Diagnostics Program of NCT Heidelberg, including the NCT/DKTK MASTER Program, and with the NCT Trial Center, including the PMO Clinical Trials Program, SarcBOP will generate a comprehensive and continuously growing resource for clinicians, researchers, and, finally, patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Healthy Volunteers: f
View:

• Suspected or proven diagnosis of soft-tissue or bone sarcoma (STBS)

• Age ≥12 years

• Ability to understand nature and individual consequences of the registry

• Written informed consent

• Subjects who are physically or mentally capable of giving consent

Locations
Other Locations
Germany
National Center for Tumour Diseases, University Hospital Heidelberg
RECRUITING
Heidelberg
Contact Information
Primary
Richard F. Schlenk, Prof.Dr.med
richard.schlenk@med.uni-heidelberg.de
+49 6221 56 6228
Backup
SarcBOP Team
sarcbop@nct-heidelberg.de
Time Frame
Start Date: 2019-07-23
Estimated Completion Date: 2032-12-31
Participants
Target number of participants: 3000
Related Therapeutic Areas
Sponsors
Leads: Prof. Dr. Richard F Schlenk

This content was sourced from clinicaltrials.gov

Similar Clinical Trials